106 Commerce Street, Suite 105
Lake Mary, FL 32746
TEL: 407.878.7606 • FAX: 407.878.7611
For additional copies: info@GuidelineCentral.com
Copyright © 2014 All rights reserved
Disclaimer
is Guideline attempts to define principles of practice that should produce high-quality patient care.
It focuses on the needs of primary care practice, but also is applicable to providers at all levels.
is Guideline should not be considered exclusive of other methods of care reasonably directed at
obtaining the same results. e ultimate judgment concerning the propriety of any course of conduct
must be made by the clinician aer consideration of each individual patient situation.
Neither IGC, the medical associations, nor the authors endorse any product or service associated with
the distributor of this clinical reference tool.
ACCVHDAS14081c
Source
Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP III, Guyton RA, O'Gara PT,
Ruiz CE, Skubas NJ, Sorajja P, Sundt TM III, omas JD. 2014 AHA/ACC guideline for
the management of patients with valvular heart disease: a report of the American College of
Cardiolog y/American Heart Association Task Force on Practice Guidelines.
J Am Coll Cardiol 2014;63:e57–185. Copublished in Circulation 2014;129:e521-e643.
This resource is provided compliments of Edwards
Lifesciences LLC. It is intended for reference use only
and healthcare providers must make clinical judgments
based on their independent assessment of each patient.
Edwards Lifesciences LLC was not involved in the
development of the underlying guidelines on which this
publication is based.
AR12009
Abbreviations
2-D, 2-dimensional, AVAi, aortic valve area indexed to body surface area; AVR, aortic valve
replacement; BP, blood pressure; CKD, chronic kidney disease; CNS, central nervous system;
COR, Class of Recommendation; CVA, cardiovascular accident (stroke); DLCO
2
, carbon
dioxide diffusing capacity of the lungs; DSE, dobutamine stress echocardiography; ECG,
electrocardiogram, FEV1, forced expiratory volume in 1 second; GI, gastrointestinal; GDMT,
guideline-directed medical therapy; HF, heart failure; INR, international normalized ratio;
LOE, Level of Evidence; LV, le ventricular; LVEF, le ventricular ejection fraction; m/s,
meters per second; NYHA, New York Heart Association; ΔP, pressure gradient; PHTN,
pulmonary hypertension, PROM, predicted risk of mortality; RCT, randomized controlled
trial; RV, right ventricular; STS, Society of oracic Surgeons; TAVR, transcatheter aortic
valve replacement; TTE, transthoracic echocardiography/echocardiogram; VKA, vitamin K
antagonist; V
max
, maximal velocity; y, year
